Cornary Artery Disease Clinical Trials
Links shared publicly online about this topic
Boston Scientific Completes Enrollment In Clinical Trial Evaluating Next-Generation Nitinol Stent To Treat Iliac Artery Disease
medicalnewstoday.com — “Boston Scientific Corporation (NYSE: BSX) announced that it has completed enrollment in the ORION clinical trial, which is designed to evaluate the Company's EPIC™ Self-Expanding Nitinol Ste” View full resource at medicalnewstoday.com
Most Recently Shared on January 11, 2011 at 4:05 pm By:
MNT Pharma News Health News and Pharma
Boston Scientific Completes Enrollment In Clinical Trial Evaluating Next-Generation Nitinol Stent To Treat Iliac Arter... http://mnt.to/3PR6
Cook Medical Releases REFORM Clinical Trial Data On Its Stent To Treat Renal Artery Disease
medicalnewstoday.com — “Study investigators reported initial data from Cook Medical's REFORM clinical trial that is aimed at assessing the safety and effectiveness of the company's balloon-expandable renal stent for the” View full resource at medicalnewstoday.com
Most Recently Shared on January 19, 2011 at 4:05 pm By:
MNT Clinical Trials Health News
Cook Medical Releases REFORM Clinical Trial Data On Its Stent To Treat Renal Artery Disease http://mnt.to/3Q9g #clinicaltrials
Lantheus Medical Imaging Initiates Phase 3 Clinical Trial Of Flurpiridaz F 18 For The Detection Of Coronary Artery Disease
medicalnewstoday.com — “Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced the initiation of the first of two Phase 3 clinical trials to assess myocardial perfusion using Positron E” View full resource at medicalnewstoday.com
Most Recently Shared on July 1, 2011 at 3:05 pm By:
MNT Clinical Trials Health News
Lantheus Medical Imaging Initiates Phase 3 Clinical Trial Of Flurpiridaz F 18 For The Detection Of Coronary Artery Dis... http://mnt.to/3XTY
Angiotech's Licensee, Cook Medical, Enrolls First Renal Artery Disease Patient In Clinical Trial Of New Drug-eluting Stent
medicalnewstoday.com — “Angiotech Pharmaceuticals, Inc. ( ANPI, TSX: ANP) announced Cook Medical, a license holder of Angiotech's paclitaxel technology, has enrolled the first patient in its landmark Formula(TM) PTX(R)” View full resource at medicalnewstoday.com
Most Recently Shared on April 22, 2010 at 2:10 pm By:
Angiotech's Licensee, Cook Medical, Enrolls First Renal Artery Disease Patient In Clinical Trial Of New Drug-eluting S... http://mnt.to/3BBm
Endocrinology Article | Coronary Artery Disease
mdlinx.com — “Clinical implications of the BARI 2D and COURAGE trials of coronary artery disease” View full resource at mdlinx.com
Most Recently Shared on December 14, 2010 at 9:13 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Clinical implications of the BARI 2D and COURAGE trials of coronary artery disease: Coronary Artery Disease http://bit.ly/hHZeGX #endo
Pluristem Therapeutics Announces First Patient Enrollment In Phase I Clinical Trial For Treatment Of Peripheral Artery Disease With PLX-PAD
medicalnewstoday.com — “Pluristem therapeutics inc. (nasdaqcm:psti) (dax:pjt), a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient (allogeneic) cell therapy products for a variety of ” View full resource at medicalnewstoday.com
Most Recently Shared on July 7, 2009 at 4:29 pm By:
MedicalNewsToday: Pluristem Therapeutics Announces First Patient Enrollment In: http://tinyurl.com/lzkkyz Full http://tinyurl.com/l4pdbn
St. Jude Medical Enrolls First Patient In FAME II Clinical Trial To Study Use Of FFR Technology In Patients With Stable Coronary Artery Disease
medicalnewstoday.com — “St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, announced today at EuroPCR that the first patient was enrolled in the FAME II (Fractional Flow Reserve (FFR)-Guided Percutaneous” View full resource at medicalnewstoday.com
Most Recently Shared on May 27, 2010 at 2:11 pm By:
St. Jude Medical Enrolls First Patient In FAME II Clinical Trial To Study Use Of FFR Technology In Patients With Stabl... http://mnt.to/3D8z
Registry results for Zilver stent in PAD
theheart.org — “In an interim analysis, the stent appeared to reduce revascularization rates and improve Rutherford score, walk distance, and walk score. A randomized trial completed enrollment last year.” View full resource at theheart.org
Most Recently Shared on May 13, 2009 at 4:40 pm By:
heartwire: Low fracture rate, clinical improvements with Zilver stent for peripheral artery disease http://bit.ly/crB6J
Management of stable coronary artery disease : The Lancet
thelancet.com — “Management of stable coronary artery disease. By - Prof Matthias E Pfisterer MD, Michael J Zellweger MD, Bernard J Gersh MBChB” View full resource at thelancet.com
Most Recently Shared on March 7, 2010 at 11:17 pm By:
Neil Mehta Physician, Doctor, Internist, and Medical Technology
Stable coronary artery disease - let sleeping dogs lie? http://bit.ly/bDIjDJ
Symposier - CREST Trial -Mayo Clinic
symposier.com — “Uploaded and shared in Youtube by: mayoclinic " Carotid artery disease increases your risk of stroke. Plaque builds up in the arteries in the neck, and if some breaks away it could travel to your brain and cut of blood flow. But results of a study published in the New England Journal of Medicine give doctors the information they need to choose the best preventive procedures for their patients.” View full resource at symposier.com
Most Recently Shared on August 10, 2010 at 6:45 pm By:
Symposier Cardiology Cardiology and Health Business
CREST Trial - Carotid artery disease increases your risk of stroke, Mayo Clinic. http://bit.ly/cXvjRl
Management of stable coronary artery disease : The Lancet
thelancet.com — “Management of stable coronary artery disease. By - Prof Matthias E Pfisterer MD, Michael J Zellweger MD, Bernard J Gersh MBChB” View full resource at thelancet.com
Most Recently Shared on March 3, 2010 at 12:24 am By:
M Auron MD Doctor, Pediatrician, Internist, and Physician
Management of stable CAD - http://bit.ly/94dzBp
Positive Interim Data From Minnow Medical Peripheral Artery Disease Trial Presented At TCT 2009 Conference
medicalnewstoday.com — “Minnow Medical, Inc., a developer of innovative products to treat artery disease, announced that positive clinical trial results using the Company's Guided Reshaping Technology (GRT™) to tre” View full resource at medicalnewstoday.com
Most Recently Shared on October 2, 2009 at 6:49 am By:
MNT Clinical Trials Health News
Positive Interim Data From Minnow Medical Peripheral Artery Disease Trial Presented At TCT 2009 Conference: Min.. http://bit.ly/13HnZ1
1st Patient In U.S Enrolled By St. John Hospital In Trial Of Peripheral Artery Disease Device
medicalnewstoday.com — “St. John Hospital and Medical Center in Detroit and Avinger, Inc., a medical device company focused on the development of innovative devices to combat peripheral artery disease, has announced the” View full resource at medicalnewstoday.com
Most Recently Shared on September 15, 2010 at 1:00 pm By:
MNT Clinical Trials Health News
1st Patient In U.S Enrolled By St. John Hospital In Trial Of Peripheral Artery Disease Device http://mnt.to/3JKz #clinicaltrials
Symposier - NEJM Roundtable: CABG vs. Stenting: Clinical Implications of the SYNTAX Trial, Part I
symposier.com — “Uploaded and Shared in Youtube by: NEJMvideo In the international SYNTAX trial, 1800 patients with three-vessel or left main coronary artery disease were randomly assigned to either revascularization with coronary-artery bypass grafting (CABG) or percutaneous coronary intervention involving drug-eluting stents. The need for repeat revascularization was significantly lower with CABG, but the risk of stroke was significantly higher — a tradeoff that must be considered in making clinical decisio” View full resource at symposier.com
Most Recently Shared on December 7, 2009 at 12:38 am By:
Symposier Cardiology Cardiology and Health Business
CABG Vs Stening, Implications of Syntax Trial. PART ONE -->http://bit.ly/6cHCfz // Shared At Symposier site
Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials : The Lancet
thelancet.com — “Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. By - Prof M...” View full resource at thelancet.com
Most Recently Shared on April 3, 2009 at 11:38 am By:
[The Lancet] [Articles] Coronary artery bypass surgery compared with percutaneous coronary intervent.. http://tinyurl.com/dduzh6
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Pharma News
The latest pharma industry news published daily. Articles from research centers, universities and prestigious journals.
-
MNT Clinical Trials
The latest clinical trials news published daily. Articles from research centers, universities and prestigious journals.
-
MNT Clinical Trials
The latest clinical trials news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
